Caffeine promotes glutamate and histamine release in the posterior hypothalamus

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 307, Issue 6, 2014, Pages R704-R710

  John, Joshi ^a   Kodama, Tohru ^b   Siegel, Jerome M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

Author keywords

Caffeine; Glutamate; Histamine; Microdialysis; Sleep

Indexed keywords

CAFFEINE; GLUTAMIC ACID; HISTAMINE; PROTEIN C FOS; 4 AMINOBUTYRIC ACID; CENTRAL STIMULANT AGENT;

ALERTNESS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; CONTROLLED STUDY; HISTAMINE RELEASE; IMMUNOHISTOCHEMISTRY; MALE; MICRODIALYSIS; NONHUMAN; POSTERIOR HYPOTHALAMUS; RAT; SLEEP; WAKEFULNESS; ANIMAL; ANIMAL BEHAVIOR; DRUG EFFECT; GENETIC PROCEDURES; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METABOLISM; NERVE CELL; SECRETION (PROCESS); SPRAGUE DAWLEY RAT; TIME;

CAFFEINE; GLUTAMATE; HISTAMINE; MICRODIALYSIS; SLEEP;

ANIMALS; BEHAVIOR, ANIMAL; BIOSENSING TECHNIQUES; CAFFEINE; CENTRAL NERVOUS SYSTEM STIMULANTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; GAMMA-AMINOBUTYRIC ACID; GLUTAMIC ACID; HISTAMINE RELEASE; HYPOTHALAMUS, POSTERIOR; MALE; MICRODIALYSIS; NEURONS; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; WAKEFULNESS;

EID: 84907158643     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00114.2014     Document Type: Article

References (47)

1. Acquas E, Tanda G, Di Chiara G. Differential effects of caffeine on dopamine and acetylcholine transmission in brain areas of drug-naive and caffeine-pretreated rats. Neuropsychopharmacology 27: 182–193, 2002.
2. Bender BG, Berning S, Dudden R, Milgrom H, Tran ZV. Sedation and performance impairment of diphenhydramine and second-generation an-tihistamines: a meta-analysis. J Allergy Clin Immunol 111: 770–776, 2003.
3. Blanco-Centurion C, Gerashchenko D, Shiromani PJ. Effects of sa-porin-induced lesions of three arousal populations on daily levels of sleep and wake. J Neurosci 27: 14041–14048, 2007.
4. Blouin AM, Fried I, Wilson CL, Staba RJ, Behnke EJ, Lam HA, Maidment NT, Karlsson KÆ, Lapierre JL, Siegel JM. Human hypo-cretin and melanin-concentrating hormone levels are linked to emotion and social interaction. Nat Commun 4: 1547, 2013.
5. Brown RE, Stevens DR, Haas HL. The physiology of brain histamine. Prog Neurobiol 63: 637–672, 2001.
6. Cirelli C, Tononi G. On the functional significance of c-fos induction during the sleep-waking cycle. Sleep 23: 9–25, 2000.
7. Dash MB, Douglas CL, Vyazovskiy VV, Cirelli C, Tononi G. Long-term homeostasis of extracellular glutamate in the rat cerebral cortex across sleep and waking states. J Neurosci 29: 620–629, 2009.
8. Deurveilher S, Lo H, Murphy JA, Burns J, Semba K. Differential c-Fos immunoreactivity in arousal-promoting cell groups following systemic administration of caffeine in rats. J Comp Neurol 498: 667–689, 2006.
9. Dixon AK, Gubitz AK, Sirinathsinghji DJS, Richardson PJ, Freeman TC. Tissue distribution of adenosine receptor mRNAs in the rat. Br J Pharmacol 118: 1461–1468, 1996.
10. Drake CL, Roehrs T, Turner L, Scofield HM, Roth T. Caffeine reversal of ethanol effects on the multiple sleep latency test, memory, and psy-chomotor performance. Neuropsychopharmacology 28: 371–378, 2003.
11. Ericson H, Blomqvist A, Kohler C. Origin of neuronal inputs to the region of the tuberomammillary nucleus of the rat brain. J Comp Neurol 311: 45–64, 1991.
12. Faucard R, Armand V, Héron A, Cochois V, Schwartz JC, Arrang JM. N-methyl-D-aspartate receptor antagonists enhance histamine neuron activity in rodent brain. J Neurochem 98: 1487–1496, 2006.
13. Ferré S, Karcz-Kubicha M, Hope BT, Popoli P, Burgueño J, Gutiér-rez MA, Casadó V, Fuxe K, Goldberg SR, Lluis C, Franco R, Ciruela F. Synergistic interaction between adenosine A2A and glutamate mGlu5 receptors: implications for striatal neuronal function. Proc Natl Acad Sci USA 99: 11940–11945, 2002.
14. Fredholm BB. Adenosine, adenosine receptors and the actions of caffeine. Pharmacol Toxicol 76: 93–101, 1995.
15. Guilleminault C, Anognos A. Narcolepsy. In: Principles and Practice of Sleep Medicine (3rd ed.), edited by Dement WC. Philadelphia, PA: Saunders, 2000, p. 676–686.
16. Haas HL, Sergeeva OA, Selbach. Histamine in the nervous system. Physiol Rev 88: 1183, 2008.
17. Hettinger BD, Lee A, Linden J, Rosin DL. Ultrastructural localization of adenosine A2A receptors suggests multiple cellular sites for modulation of GABAergic neurons in rat striatum. J Comp Neurol 431: 331–346, 2001.
18. Hong ZY, Huang ZL, Qu WM, Eguchi N, Urade Y, Hayaishi O. An adenosine A receptor agonist induces sleep by increasing GABA release in the tuberomammillary nucleus to inhibit histaminergic systems in rats. J Neurochem 92: 1542–1549, 2005.
19. Huang ZL, Qu WM, Li WD, Mochizuki T, Eguchi N, Watanabe T, Urade Y, Hayaishi O. Arousal effect of orexin A depends on activation of the histaminergic system. Proc Natl Acad Sci USA 98: 9965–9970, 2001.
20. John J, Ramanathan L, Siegel JM. Rapid changes in glutamate levels in the posterior hypothalamus across sleep-wake states in freely behaving rats. Am J Physiol Regul Integr Comp Physiol 295: R2041–R2049, 2008.
21. John J, Thannickal TC, McGregor R, Ramanathan L, Ohtsu H, Nishino S, Sakai N, Yamanaka A, Stone C, Cornford M, Siegel JM. Greatly increased numbers of histamine cells in human narcolepsy with cataplexy. Ann Neurol 74: 786–793, 2013.
22. John J, Wu MF, Boehmer LN, Siegel JM. Cataplexy-active neurons in the hypothalamus: implications for the role of histamine in sleep and waking behavior. Neuron 42: 619–634, 2004.
23. John J, Wu MF, Kodama T, Siegel JM. Intravenously administered hypocretin-1 alters brain amino acid release: an in vivo microdialysis study in rats. J Physiol 548: 557–562, 2003.
24. Johnson LC, Spinweber CL, Gomez SA. Benzodiazepines and caffeine: effect on daytime sleepiness, performance, and mood. Psychopharmacol-ogy (Berl) 101: 160–167, 1990.
25. Kim SW, Bae KY, Shin HY, Kim JM, Shin IS, Kim JK, Kang G, Yoon JS. Caffeine counteracts impairments in task-oriented psychomotor performance induced by chlorpheniramine: a double-blind placebo-controlled crossover study. J Psychopharmacol (Oxf) 27: 62–70, 2013.
26. Kodama T, Honda Y. Acetylcholine and glutamate release during sleep-wakefulness in the pedunculopontine tegmental nucleus and norepineph-rine changes regulated by nitric oxide. Psychiatry Clin Neurosci 53: 109–111, 1999.
27. Konadhode RR, Pelluru D, Blanco-Centurion C, Zayachkivsky A, Liu M, Uhde T, Glen WB Jr, van den Pol AN, Mulholland PJ, Shiromani PJ. Optogenetic stimulation of MCH neurons increases sleep. J Neurosci 33: 10257–10263, 2013.
28. Kostin A, Siegel JM, Alam MN. Lack of hypocretin signaling attenuates behavioral changes produced by glutamatergic activation of the perifor-nical-lateral hypothalamic area. Sleep 37: 1011–1020, 2014.
29. Lazarus M, Shen HY, Cherasse Y, Qu WM, Huang ZL, Bass CE, Winsky-Sommerer R, Semba K, Fredholm BB, Boison D, Hayaishi O, Urade Y, Chen JF. Arousal effect of caffeine depends on adenosine A2A receptors in the shell of the nucleus accumbens. J Neurosci 31: 10067–10075, 2011.
30. Liguori A, Robinson JH. Caffeine antagonism of alcohol induced driving impairment. Drug Alcohol Depend 63: 123–129, 2001.
31. Lin JS. Brain structures and mechanisms involved in the control of cortical activation and wakefulness, with emphasis on the posterior hypo-thalamus and histaminergic neurons. Sleep Med Rev 4: 471–503, 2000.
32. Lin JS, Hou Y, Jouvet M. Potential brain neuronal targets for amphetamine-, methylphenidate-, and modafinil-induced wakefulness, evidenced by c-fos immunocytochemistry in the cat. Proc Natl Acad Sci USA 93: R14128–14133, 1996.
33. Lin JS, Sakai K, Vanni-Mercier G, Jouvet M. A critical role of the posterior hypothalamus in the mechanisms of wakefulness determined by microinjection of muscimol in freely moving cats. Brain Res 479: 225–240, 1989.
34. McGinty DJ. Somnolence, recovery and hyposomnia following ventro-medial diencephalic lesions in the rat. Electroencephalogr Clin Neuro-physiol 26: 70–79, 1969.
35. Nitz D, Siegel JM. GABA release in posterior hypothalamus across sleep-wake cycle. Am J Physiol Regul Integr Comp Physiol 271: R1707–R1712, 1996.
36. Okakura K, Yamatodani A, Mochizuki T, Horii A, Wada H. Gluta-matergic regulation of histamine release from rat hypothalamus. Eur J Pharmacol 213: 189–192, 1992.
37. Oishi Y, Huang ZL, Fredholm BB, Urade Y, Hayaishi O. Adenosine in the tuberomammillary nucleus inhibits the histaminergic system via A1 receptors and promotes non-rapid eye movement sleep. Proc Natl Acad Sci USA 105: 19992–19997, 2008.
38. Paterson LM, Wilson SJ, Nutt DJ, Hutson PH, Ivarsson M. Characterisation of the effects of caffeine on sleep in the rat: a potential model of sleep disruption. J Psychopharmacol (Oxf) 23: 475–486, 2009.
39. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. San Diego, CA: Academic, 1997.
40. Salin-Pascual R, Gerashchenko D, Greco M, Blanco-Centurion C, Shiromani PJ. Hypothalamic regulation of sleep. Neuropsychopharma-cology 25: S21–S27, 2001.
41. Satoh S, Matsumura H, Suzuki F, Hayaishi O. Promotion of sleep mediated by the A2a-adenosine receptor and possible involvement of this receptor in the sleep induced by prostaglandin D2 in rats. Proc Natl Acad Sci USA 93: 5980–5984, 1996.
42. Sherin JE, Elmquist JK, Torrealba F, Saper CB. Innervation of histaminergic tuberomammillary neurons by GABAergic and galaninergic neurons in the ventrolateral preoptic nucleus of the rat. J Neurosci 18: 4705–4721, 1998.
43. Solinas M, Ferré S, You ZB, Karcz-Kubicha M, Popoli P, Goldberg SR. Caffeine induces dopamine and glutamate release in the shell of the nucleus accumbens. J Neurosci 22: 6321–6324, 2002.
44. Torrealba F, Yanagisawa M, Saper CB. Colocalization of orexin and glutamate immunoreactivity in axon terminals in the tuberomammillary nucleus in rats. Neuroscience 119: 1033–1044, 2003.
45. von Economo C. Sleep as a problem of localization. J Nerv Met Dis 71: 249–259, 1930.
46. Wu MF, Gulyani SA, Yau E, Mignot E, Phan B, Siegel JM. Locus coeruleus neurons: cessation of activity during cataplexy. Neuroscience 91: 1389–1399, 1999.
47. Yang QZ, Hatton GI. Electrophysiology of excitatory and inhibitory afferents to rat histaminergic tuberomammillary nucleus neurons from hypothalamic and forebrain sites. Brain Res 773: 162–172, 1997.